Efficacy and Acceptability of a Monkeypox Curriculum for Disproportionately Impacted Communities
1 other identifier
interventional
200
1 country
1
Brief Summary
The study team will create an online module via the REDCap platform. The module will include around 5 videos and several infographics covering the topics of symptoms, transmission, prevention, vaccination, and treatment of the monkeypox virus. Surveys assessing the primary and secondary study endpoints will be given to participants before and after the module. The purpose of the study is to assess the efficacy and acceptability of an educational presentation on monkeypox in a cohort of individuals recruited from Rainbow Health and to secondarily assess participant risk perception, intention to vaccinate, and confidence in public health initiatives.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 26, 2022
CompletedFirst Posted
Study publicly available on registry
December 15, 2022
CompletedStudy Start
First participant enrolled
May 24, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 24, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 24, 2023
CompletedOctober 4, 2023
October 1, 2023
3 months
November 26, 2022
October 3, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
Efficacy of intervention
Efficacy of intervention will be measured by changes in knowledge using a survey
baseline
Efficacy of intervention
Efficacy of intervention will be measured by changes in knowledge using a survey
immediately after intervention
Acceptability
Acceptability will be measured by a validated questionnaire based on the Theoretical Framework of Acceptability.
immediately after intervention
Secondary Outcomes (6)
risk perception
baseline
risk perception
immediately after intervention
intention to vaccinate
baseline
intention to vaccinate
immediately after intervention
confidence in public health initiatives
baseline
- +1 more secondary outcomes
Interventions
online module including around 5 videos and several infographics covering the topics of symptoms transmission, prevention, vaccination, and treatment of the monkeypox virus.
Eligibility Criteria
You may qualify if:
- Individuals who are 18 years and older
- Individuals able to read and write in English
You may not qualify if:
- Unable to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Minnesota
Minneapolis, Minnesota, 55455, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Matthew Mansh, MD
University of Minnesota
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 26, 2022
First Posted
December 15, 2022
Study Start
May 24, 2023
Primary Completion
August 24, 2023
Study Completion
August 24, 2023
Last Updated
October 4, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share